• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病致病变体:跨血统分析与微阵列数据验证

Parkinson's Disease Pathogenic Variants: Cross-Ancestry Analysis and Microarray Data Validation.

作者信息

Hong Samantha, Koretsky Mathew J, Lichtenberg Jens, Leonard Hampton, Pitz Vanessa

机构信息

Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, USA.

DataTecnica LLC, Washington DC, USA.

出版信息

medRxiv. 2024 Dec 17:2024.12.16.24319097. doi: 10.1101/2024.12.16.24319097.

DOI:10.1101/2024.12.16.24319097
PMID:39763553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11702716/
Abstract

BACKGROUND

Known pathogenic variants in Parkinson's disease (PD) contribute to disease development but have yet to be fully explored by arrays at scale.

OBJECTIVES

This study evaluated genotyping success of the NeuroBooster array (NBA) and determined the frequencies of pathogenic variants across ancestries.

METHOD

We analyzed the presence and allele frequency of 34 pathogenic variants in 28,710 PD cases, 9,614 other neurodegenerative disorder cases, and 15,821 controls across 11 ancestries within the Global Parkinson's Genetics Program dataset. Of these, 25 were genotyped on NBA and cluster plots were used to assess their quality.

RESULTS

Genes previously predicted to have high or very high confidence of causing PD tend to have more pathogenic variants and are present across ancestry groups. Twenty-five of the 34 pathogenic variants were typed by the NBA array and classified "good" (n=12), "medium" (n=4), and "bad" (n=9) variants.

CONCLUSION

Our results confirm the likelihood that established PD genes are pathogenic and highlight the importance of ancestrally diverse research in PD. We also show the usefulness of the NBA as a reliable tool for genotyping of rare variants for PD.

摘要

背景

帕金森病(PD)中已知的致病变异有助于疾病发展,但尚未通过大规模阵列进行充分探索。

目的

本研究评估了NeuroBooster阵列(NBA)的基因分型成功率,并确定了不同祖先群体中致病变异的频率。

方法

我们在全球帕金森病遗传学项目数据集中分析了28710例PD病例、9614例其他神经退行性疾病病例和15821例对照中34个致病变异的存在情况和等位基因频率,这些病例来自11个祖先群体。其中,25个变异在NBA上进行了基因分型,并使用聚类图评估其质量。

结果

先前预测导致PD具有高置信度或非常高置信度(的致病变异)往往有更多的致病变异,并且在不同祖先群体中均有存在。34个致病变异中的25个通过NBA阵列分型,并分为“良好”(n = 12)、“中等”(n = 4)和“不良”(n = 9)变异。

结论

我们的结果证实了已确定的PD基因具有致病性的可能性,并强调了PD中不同祖先群体研究的重要性。我们还展示了NBA作为PD罕见变异基因分型可靠工具的实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0507/11702716/a60d57603ede/nihpp-2024.12.16.24319097v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0507/11702716/a60d57603ede/nihpp-2024.12.16.24319097v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0507/11702716/a60d57603ede/nihpp-2024.12.16.24319097v1-f0001.jpg

相似文献

1
Parkinson's Disease Pathogenic Variants: Cross-Ancestry Analysis and Microarray Data Validation.帕金森病致病变体:跨血统分析与微阵列数据验证
medRxiv. 2024 Dec 17:2024.12.16.24319097. doi: 10.1101/2024.12.16.24319097.
2
NeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations.神经增强阵列:一个用于在不同人群中研究神经疾病的全基因组基因分型平台。
medRxiv. 2023 Nov 14:2023.11.06.23298176. doi: 10.1101/2023.11.06.23298176.
3
NeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations.神经增强阵列:一个全基因组基因分型平台,用于研究不同人群中的神经障碍。
Mov Disord. 2024 Nov;39(11):2039-2048. doi: 10.1002/mds.29902. Epub 2024 Sep 16.
4
Large-scale genetic characterization of Parkinson's disease in the African and African admixed populations.非洲及非洲裔混血人群中帕金森病的大规模基因特征分析。
medRxiv. 2025 Jan 20:2025.01.14.25320205. doi: 10.1101/2025.01.14.25320205.
5
Population-Specific Differences in Pathogenic Variants of Genes Associated with Monogenic Parkinson's Disease.单基因帕金森病相关基因致病性变异的人群特异性差异
Genes (Basel). 2025 Apr 15;16(4):454. doi: 10.3390/genes16040454.
6
Biobank-scale characterization of Alzheimer's disease and related dementias identifies potential disease-causing variants, risk factors, and genetic modifiers across diverse ancestries.阿尔茨海默病及相关痴呆症的生物样本库规模特征分析确定了不同血统中潜在的致病变异、风险因素和基因修饰因子。
medRxiv. 2024 Nov 17:2024.11.03.24313587. doi: 10.1101/2024.11.03.24313587.
7
Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinson's Disease in African and African Admixed Populations.全基因组关联研究揭示非洲及非裔混血人群中与帕金森病相关的新病因学见解。
medRxiv. 2023 May 7:2023.05.05.23289529. doi: 10.1101/2023.05.05.23289529.
8
The effect of polygenic risk score on PD risk and phenotype in G2019S and carriers.多基因风险评分对G2019S及携带者帕金森病风险和表型的影响。
J Parkinsons Dis. 2025 Mar;15(2):291-299. doi: 10.1177/1877718X241310722. Epub 2025 Jan 17.
9
Does Play a Role in Parkinson's Disease Susceptibility Across Diverse Ancestral Populations?在不同祖先群体的帕金森病易感性中起作用吗?
medRxiv. 2025 Apr 11:2025.04.11.25325572. doi: 10.1101/2025.04.11.25325572.
10
Heterozygous PRKN mutations are common but do not increase the risk of Parkinson's disease.杂合性 PRKN 突变很常见,但不会增加帕金森病的风险。
Brain. 2022 Jun 30;145(6):2077-2091. doi: 10.1093/brain/awab456.

本文引用的文献

1
GenoTools: an open-source Python package for efficient genotype data quality control and analysis.GenoTools:一个用于高效基因型数据质量控制和分析的开源Python软件包。
G3 (Bethesda). 2025 Jan 8;15(1). doi: 10.1093/g3journal/jkae268.
2
NeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations.神经增强阵列:一个全基因组基因分型平台,用于研究不同人群中的神经障碍。
Mov Disord. 2024 Nov;39(11):2039-2048. doi: 10.1002/mds.29902. Epub 2024 Sep 16.
3
Parkinson's Disease is Predominantly a Genetic Disease.
帕金森病主要是一种遗传疾病。
J Parkinsons Dis. 2024;14(3):467-482. doi: 10.3233/JPD-230376.
4
Parkinson's Disease Is Predominantly an Environmental Disease.帕金森病主要是一种环境性疾病。
J Parkinsons Dis. 2024;14(3):451-465. doi: 10.3233/JPD-230357.
5
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study.在非洲和非洲混合人群中与帕金森病相关的遗传风险基因座和因果关系的鉴定:一项全基因组关联研究。
Lancet Neurol. 2023 Nov;22(11):1015-1025. doi: 10.1016/S1474-4422(23)00283-1. Epub 2023 Aug 23.
6
Underrepresented Populations in Parkinson's Genetics Research: Current Landscape and Future Directions.帕金森遗传学研究中的代表性不足人群:现状与未来方向。
Mov Disord. 2022 Aug;37(8):1593-1604. doi: 10.1002/mds.29126. Epub 2022 Jul 22.
7
Next-Generation Sequencing Analysis of : The Challenge of Detecting Complex Recombinant Alleles.下一代测序分析:检测复杂重组等位基因的挑战
Front Genet. 2021 Jun 21;12:684067. doi: 10.3389/fgene.2021.684067. eCollection 2021.
8
Characterizing the Genetic Architecture of Parkinson's Disease in Latinos.探讨拉丁裔人群帕金森病的遗传结构特征。
Ann Neurol. 2021 Sep;90(3):353-365. doi: 10.1002/ana.26153. Epub 2021 Jul 22.
9
Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study.亚洲人群帕金森病风险基因座的鉴定及亚洲人与欧洲人风险比较的全基因组关联研究。
JAMA Neurol. 2020 Jun 1;77(6):746-754. doi: 10.1001/jamaneurol.2020.0428.
10
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.帕金森病的新风险基因座鉴定、因果关系洞察和遗传风险:全基因组关联研究的荟萃分析。
Lancet Neurol. 2019 Dec;18(12):1091-1102. doi: 10.1016/S1474-4422(19)30320-5.